Pyxis Oncology Stock Price on December 5, 2024
| PYXS Stock | USD 1.64 0.04 2.38% |
If you're considering investing in Pyxis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pyxis Oncology stands at 1.64, as last reported on the 11th of December 2024, with the highest price reaching 1.64 and the lowest price hitting 1.64 during the day. Pyxis Oncology maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Pyxis Oncology exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pyxis Oncology's Coefficient Of Variation of (878.47), variance of 52.12, and Risk Adjusted Performance of (0.07) to confirm the risk estimate we provide.
Other Stockholder Equity is likely to gain to about 432.4 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 116.5 M in 2024. . At this time, Pyxis Oncology's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.02 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.07) in 2024. Pyxis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pyxis |
Sharpe Ratio = -0.1213
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PYXS |
Estimated Market Risk
| 7.32 actual daily | 65 65% of assets are less volatile |
Expected Return
| -0.89 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pyxis Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pyxis Oncology by adding Pyxis Oncology to a well-diversified portfolio.
Price Book 0.6888 | Enterprise Value Ebitda 1.0881 | Price Sales 6.5557 | Shares Float 39.1 M | Wall Street Target Price 10.6667 |
Related Headline
Elevation Oncology Headline on 5th of December 2024
Elevation Oncology Presents Preclinical Proof-of-Concept Dat... by finance.yahoo.com
Elevation Oncology, Inc. , an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced new preclinical data demonstrating the combination potential of EO-3021, a Claudin 18.2 antibody-drug conjugate , with VEGFR2 or PD-1 inhibitors. The data will be presented in a poster session at the European Society for Medical Oncology Immuno-Onco
Pyxis Oncology Valuation on December 5, 2024
It is possible to determine the worth of Pyxis Oncology on a given historical date. On December 5, 2024 Pyxis was worth 1.79 at the beginning of the trading date compared to the closed value of 1.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pyxis Oncology stock. Still, in general, we apply an absolute valuation method to find Pyxis Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pyxis Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pyxis Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 1.89 | 1.89 | 1.79 | 1.80 | 1,357,552 | |
12/05/2024 | 1.79 | 1.81 | 1.67 | 1.70 | 1,916,395 |
| 1.70 | 1.73 | 1.65 | 1.67 | 1,181,964 |
| Backtest Pyxis Oncology | | | Pyxis Oncology History | | | Pyxis Oncology Valuation | Previous | Next |
Pyxis Oncology Trading Date Momentum on December 5, 2024
| On December 06 2024 Pyxis Oncology was traded for 1.67 at the closing time. The top price for the day was 1.73 and the lowest listed price was 1.65 . The trading volume for the day was 1.2 M. The trading history from December 6, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.76% . The trading delta at closing time against the current closing price is 1.18% . |
Pyxis Oncology Fundamentals Correlations and Trends
By evaluating Pyxis Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pyxis Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pyxis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pyxis Oncology Stock history
Pyxis Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pyxis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pyxis Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pyxis Oncology stock prices may prove useful in developing a viable investing in Pyxis Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 39.9 M | 38.2 M | |
| Net Loss | -108.6 M | -103.2 M |
Pyxis Oncology Quarterly Net Working Capital |
|
Pyxis Oncology Stock Technical Analysis
Pyxis Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pyxis Oncology Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Pyxis Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pyxis Oncology December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Pyxis Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pyxis Oncology shares will generate the highest return on investment. By undertsting and applying Pyxis Oncology stock market strength indicators, traders can identify Pyxis Oncology entry and exit signals to maximize returns
Pyxis Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pyxis Oncology's price direction in advance. Along with the technical and fundamental analysis of Pyxis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pyxis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.98) | |||
| Treynor Ratio | 2.33 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pyxis Stock Analysis
When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.